Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

2917 - Staging and assessment of the response to PET-CT treatment in non-small cell lung carcinoma


09 Sep 2017


Poster display session


Staging Procedures (not Imaging);  Non-Small Cell Lung Cancer


Miriam Mendez Garcia


Annals of Oncology (2017) 28 (suppl_5): v568-v572. 10.1093/annonc/mdx389


M. Mendez Garcia1, M.A. Brenes2, R. Gómez2, M. Soriano2, M. Torrente1, C. Maximiano2, G. Díaz3, B. Rodríguez4, M.D.M. Córdoba5, M. Provencio Pulla6

Author affiliations

  • 1 Medical Oncology, Hospital University Puerta de Hierro, 28222 - Majadahonda/ES
  • 2 Oncologia Medica, Hospital Universitario Puerta de Hierro, 28222 - Madrid/ES
  • 3 Neumologia, Hospital Universitario Puerta de Hierro, 28222 - Madrid/ES
  • 4 Medicina Nuclear, Hospital Universitario Puerta de Hierro, 28222 - Madrid/ES
  • 5 Thoracic Surgery, Hospital Universitario Puerta de Hierro, 28222 - Madrid/ES
  • 6 Servicio De Oncología Médica, Hospital Universitario Puerta de Hierro Majadahond, 28222 - Majadahonda/ES


Abstract 2917


Non-small cell lung cancer (NSCLC) is the leading cause of death from tumors in Western countries. Mediastinal involvement is the most important factor to determine treatment and prognosis. The aim of this study was to analyze the concordance between histological mediastinal staging with that demonstrated by positron emission tomography and computed tomography (PET-CT), in addition to defining the characteristics of this population.


We prospectively evaluated 244 patients diagnosed with NSCLC at Puerta de Hierro Hospital, from 2009 to 2016. Mediastinal staging was determined by imaging (CT and PET- CT) and anatomo-pathological examination (endobronchial ultrasound, mediastinoscopy or lymphadenectomy). Variables collected included tumor size by CT and PET- CT, lymph node involvement, treatment, and survival. The findings of PET-CT were compared with the histological findings to determine the sensitivity, specificity, and positive (PPV) and negative (NPV) predictive values.


Median of age was 66 years, 74% patients were male,22% were non-smokers. Most common histologies were adenocarcinoma (45%) and squamous (37%). 12% patients presented EGFR mutations (64% 19del) and 3%were ALK-translocated. Staging results by PET-CT were: I (26%), II (21%), III (A 26% and B 14%) and IV (10%).

The correlation in staging between CT and PET-CT, obtaining a kappa index of 0.9 (p 


According to the data observed in our series, there is a strong concordance between the two radiological tests for staging of NSCLC (PET-CT and CT). There is also agreement between PET-CT and subsequent pathological findings in NSCLC in initial stages (I and II). Because of the high sensitivity and NPV of the PET-CT for mediastinal staging, a positive result of this test requires an histological correlation.The increase in the use of PET- CT contributes to more accurate selection of patients for appropriate treatment.

Clinical trial identification

Legal entity responsible for the study

Puerta de Hierro University Hospital




All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.